Topical and dermatology Rx products

Specialty chemicals; near-monopoly on Carbopol cross-linked polyacrylic acid gelling agents.

Leading US manufacturer of USP/EP white petrolatum and pharmaceutical mineral oils; owned by HollyFrontier (now HF Sinclair); refines petroleum-derived waxes and soft solids used as ointment bases, excipients, and cosmetic raw materials. Sonneborn's Carnation® white petrolatum is the benchmark pharmaceutical-grade reference standard.

Indian fermentation-based API specialist; leading global maker of immunosuppressant APIs (tacrolimus, sirolimus, mycophenolate) and other fermentation products.

Largest specialty asphalt/bitumen producer in the US for roofing applications. Operates three roofing-focused refineries: Princeton, LA (primary roofing flux); Shreveport, LA; Great Falls, MT. Princeton refinery specializes in roofing flux and coating asphalt for shingle manufacturing. Key supplier to GAF, Owens Corning, CertainTeed and other shingle makers.

Major Indian pharmaceutical company (NYSE: RDY); one of India's largest generic drug manufacturers. Major tretinoin API producer; also produces wide range of generic APIs and formulations for US, EU, and global markets. Second-largest Indian pharma company by revenue. API manufacturing in Hyderabad, Vizag (Visakhapatnam), and other sites.

One of the world's largest manufacturers of generic topical dermatology products; ~40% market share in US generic corticosteroid creams and ointments; owned by Sun Pharmaceutical Industries (India); manufactures in Israel, Canada, and US; controls a significant share of the US generic topical market for high-potency steroids.

Indian API and formulation manufacturer; one of the key tretinoin API producers. Major supplier of generic API to US, EU, and global markets. BSE/NSE listed. Ratlam (Madhya Pradesh) and other facilities. IPCA was subject to FDA import alert in 2015 affecting US supply of multiple APIs -- demonstrating how a single enforcement action against one Indian API manufacturer can create shortage of multiple drugs simultaneously.

India's largest petroleum wax and white petrolatum manufacturer; produces USP/EP-grade white petrolatum for pharmaceutical and personal care applications. Part of the Hinduja Group. Thane, Maharashtra primary production site. Major supplier of pharmaceutical-grade petrolatum to Asian and global markets. BSE-listed.

Major Indian pharmaceutical company with significant US generic topical dermatology business; one of the top 5 US market share holders in prescription topical steroids; also develops novel dermatology molecules; manufactures corticosteroid and antifungal APIs and finished products for US/EU markets.

Specialty chemical company; acquired International Specialty Products (ISP) in 2011 bringing the leading US NMP production capacity; manufactures high-purity NMP for medical, electronics, and battery applications; one of five major Western NMP suppliers serving medical-grade dialysis membrane production alongside BASF, Eastman, LyondellBasell, and Mitsubishi Chemical

Indian pharmaceutical API manufacturer (NSE: DIVISLAB, HQ Hyderabad; ~₹75B revenue); one of India's largest and most technically sophisticated pharmaceutical API producers, specializing in complex APIs including fluoroquinolones (ciprofloxacin, ofloxacin, levofloxacin), carotenoids (nutraceuticals), and custom synthesis for branded pharmaceutical companies. Divi's Laboratories has never been involved in a major USFDA warning letter or import alert (unusual for an Indian API company of its scale) — maintaining essentially clean regulatory compliance across its multiple Visakhapatnam, Andhra Pradesh production facilities. Divi's produces fluoroquinolone APIs including ciprofloxacin HCl for ophthalmic applications for global generic pharmaceutical customers. Divi's is also one of India's most consistently profitable pharmaceutical companies — its focus on volume API production at high quality has created a near-uninterruptible supply chain position across multiple essential medicines.

Major Chinese steroidal API producer; one of China's largest pharmaceutical companies by API volume. Produces corticosteroid intermediates and finished APIs (betamethasone valerate, triamcinolone acetonide, and others) from phytosterol precursors (primarily from soybean processing). Listed on Shenzhen Stock Exchange. Also produces analgesics and antipyretics.

Chinese pharmaceutical and personal care carbomer producer; one of the largest non-Lubrizol carbomer manufacturers. Produces cross-linked polyacrylic acid (carbomer) for personal care and some pharmaceutical applications at lower price points than Lubrizol Carbopol. Growing market share as pharmaceutical formulators seek alternatives to Lubrizol after COVID-era supply shock.

German specialty chemicals company; major producer of methyl mercaptan (used in methionine synthesis for animal feed) and other organosulfur chemicals. Also produces specialty sulfur chemicals including mercaptan blends used in gas odorization. Evonik's organosulfur chemicals are primarily focused on methionine production (world's largest DL-methionine producer under 'EVONIK MetAMINO' brand) — methionine is the most important amino acid supplement for poultry and aquaculture. Same mercaptan chemistry used in safety odorants also underpins the global animal feed amino acid supply chain.

Italian specialty corticosteroid API manufacturer; one of few European producers of pharmaceutical-grade corticosteroid bulk actives (betamethasone, triamcinolone, clobetasol, fluocinolone). Serves as alternative non-Asian source for European regulated markets. Part of Zambon Group. European regulatory compliance (EU GMP) provides competitive advantage for EU-based pharmaceutical companies sourcing corticosteroid APIs.

Archer-Daniels-Midland Company (Chicago IL; NYSE: ADM; ~$85B revenue FY2023; founded 1902) is the world's largest agricultural commodity processor and a major corn merchandiser supplying livestock feed. ADM's AG Services and Oilseeds segment operates 270+ facilities including corn origination elevators throughout Iowa, Illinois, Indiana, Nebraska, and Minnesota. ADM's Animal Nutrition segment produces lysine, threonine, and other amino acid feed additives used in swine feed premixes globally. ADM's corn wet milling operations (Decatur IL flagship plant; Cedar Rapids IA) produce corn starch, corn syrup, corn oil, ethanol, and DDGS (distillers dried grains with solubles) — DDGS is sold as a protein-energy supplement in swine diets at inclusion rates of 10-20%. ADM is simultaneously the largest US corn merchandiser, a producer of DDGS feed ingredients, and a supplier of amino acid additives that enable lower-protein corn-soy diets in hog production. ADM faced a significant accounting investigation in 2023-2024: the company disclosed that its Nutrition segment had misreported results; CEO Juan Luciano resigned in January 2024 amid DOJ/SEC inquiry, creating management uncertainty during a period of corn market volatility.

Japanese pharmaceutical company; originator of tacrolimus (FK506 / Protopic®) for atopic dermatitis and Prograf® for organ transplant; tacrolimus was discovered from soil bacterium Streptomyces tsukubaensis sampled near Mount Tsukuba, Japan in 1984; the dermatology formulation opened a new non-steroidal treatment class.